Is amitriptyline appropriate for treating functional ENT disorders such as tinnitus, vestibular migraine, globus pharyngeus, chronic refractory cough, and laryngeal sensory neuropathy?

Amitriptyline in Functional ENT Disorders

Amitriptyline can be effective for several functional ENT disorders, but guideline support varies significantly by condition: it should NOT be routinely used for tinnitus, was excluded from chronic cough guidelines due to verification concerns despite positive effects, but shows promise for globus pharyngeus, laryngeal sensory neuropathy, and vestibular migraine based on research evidence.

Condition-Specific Recommendations

Tinnitus: NOT Recommended

The American Academy of Otolaryngology explicitly recommends AGAINST routine use of antidepressants (including amitriptyline) for persistent, bothersome tinnitus 1. This Grade B recommendation is based on RCTs and systematic reviews showing insufficient evidence to justify routine use, especially given known harms, costs, and the potential for some antidepressants to worsen tinnitus itself 1.

• Caveat: One older RCT (2001) showed 95% treatment success with amitriptyline 100 mg/day versus 12% with placebo 2, but this single study is outweighed by the guideline's systematic assessment
• First-line approaches should be: hearing aid evaluation (if hearing loss present), cognitive-behavioral therapy, sound therapy, and education/counseling 1

Chronic Refractory Cough: Excluded from Guidelines

The 2016 CHEST guidelines on unexplained chronic cough specifically excluded amitriptyline from recommendations despite positive effects on cough-specific quality of life because investigators were unable to verify the reporting of results 3.

• Gabapentin received a weak recommendation instead (starting dose based on Ryan trial, with risk-benefit reassessment at 6 months) 3
• The guideline noted that amitriptyline, gabapentin, and morphine all showed positive effects exceeding minimum important differences in quality of life measures 3
• If considering amitriptyline off-guideline: typical dosing would be 10-100 mg at bedtime, starting low

Globus Pharyngeus: Effective

Low-dose amitriptyline (25 mg) demonstrates significant efficacy for globus pharyngeus, superior to proton pump inhibitor therapy 4.

• Treatment response (>50% symptom reduction): 75% with amitriptyline versus 35.7% with pantoprazole (P=0.004) 4
• Rapid onset: significant improvement by day 3 (GETS score 3.69 vs 5.64, P<0.001) 4
• Additional benefits: improved sleep quality and quality of life measures (general health, vitality, social functioning, mental health) 4
• Dosing: 25 mg before bedtime for 4 weeks
• Common side effects: dry mouth, sleepiness, dizziness, constipation—but well tolerated at this low dose 4

Laryngeal Sensory Neuropathy: Effective

Amitriptyline is a recognized treatment for laryngeal sensory neuropathy (also called sensory neuropathic cough), though newer evidence suggests mirtazapine may be superior for refractory cases 5, 6, 7.

• Initial trial of amitriptyline 10 mg: 75-100% short-term relief in most patients with chronic nonproductive cough lasting months to years 5
• Broader study: 56.1% overall improvement rate (32% complete response, 24% partial response) 6
• No differences in efficacy by gender, age, or race 6
• 23% reported sedation; 8% unable to tolerate treatment 6
• For amitriptyline failures: Consider mirtazapine 30 mg, which showed significant improvement in patients who did not respond to gabapentin and/or amitriptyline 7

Vestibular Migraine: Moderately Effective

Amitriptyline is one of several oral prophylactic options for vestibular migraine, with comparable efficacy to propranolol and flunarizine 8.

• All three medications (propranolol, flunarizine, amitriptyline) showed statistically significant reductions in Dizziness Handicap Inventory scores, Migraine Disability Assessment Scale scores, and vertigo attack frequencies 8
• No significant difference between medication types in effectiveness 8
• Important: Migraine dietary/lifestyle modifications alone may be equally or more effective than medication, with one study showing superior reduction in dizziness (VAS decrease 5.1 vs 1.8) and stress levels compared to nortriptyline (a related tricyclic) 9
• Optimal approach: Combine medication with dietary/lifestyle modifications rather than medication alone 9
• Note: Nortriptyline (10-40 mg) is an alternative tricyclic with similar mechanism and potentially fewer anticholinergic effects 9

Practical Prescribing Considerations

Dosing Strategy

• Start low: 10-25 mg at bedtime
• Titrate gradually: Increase by 10-25 mg every 1-2 weeks based on response and tolerability
• Typical therapeutic range: 25-100 mg/day for most functional ENT disorders
• Timing: Always at bedtime to leverage sedative effects and minimize daytime impairment

Key Side Effects (FDA Label)

The most relevant anticholinergic and CNS effects include 10:

• Anticholinergic: Dry mouth, blurred vision, constipation, urinary retention, tachycardia
• CNS: Drowsiness, dizziness, confusion (especially in elderly), cognitive impairment
• Cardiovascular: Orthostatic hypotension, arrhythmias, ECG changes
• Other: Weight gain, tinnitus (paradoxically), withdrawal symptoms if stopped abruptly

Critical Warnings

• Elderly patients: Particularly sensitive to anticholinergic effects; increased fall risk; start with lowest doses 10
• Contraindications: MAO inhibitors, acute MI recovery period, narrow-angle glaucoma
• Drug interactions: CYP2D6 inhibitors (SSRIs, cimetidine) increase levels; anticholinergic drugs compound effects 10
• Suicide risk: Black box warning for increased suicidal thinking in young adults; not established as safe in pediatrics 10

Monitoring

• Reassess response at 4-6 weeks
• Monitor for anticholinergic burden, especially in elderly
• Gradual taper if discontinuing (avoid abrupt cessation to prevent withdrawal symptoms) 10

Clinical Algorithm

1. Tinnitus: Do NOT use amitriptyline routinely; pursue hearing aids, CBT, sound therapy per guidelines 1

2. Chronic refractory cough: Consider gabapentin first per guidelines; amitriptyline off-guideline if gabapentin fails 3

3. Globus pharyngeus: Trial amitriptyline 25 mg at bedtime for 4 weeks—strong research support 4

4. Laryngeal sensory neuropathy: Start amitriptyline 10 mg at bedtime, titrate to effect; if fails, consider mirtazapine 30 mg 5, 6, 7

5. Vestibular migraine: Amitriptyline is reasonable (comparable to propranolol/flunarizine), but MUST combine with dietary/lifestyle modifications for optimal results 9, 8